Physician Data Query

Last uploaded: April 29, 2019
Preferred Name

therapeutic epinephrine

Definitions

The synthetic form of the naturally occurring sympathomimetic amine with bronchodilating, intraocular pressure reducing, and vasoconstricting activity. By stimulating alpha adrenergic receptors, this agent causes vasoconstriction, thereby increasing vascular resistance and blood pressure. When administered in the conjunctiva, epinephrine binds to alpha-adrenergic receptors in the iris sphincter muscle, thereby causing vasoconstriction and a decrease in the production of aqueous humor. Through its beta1-receptor stimulating actions, this agent increases the force and rate of myocardial contraction and relaxes bronchial smooth muscle, thereby causing bronchodilatation. Check for "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=41857&idtype=1" active clinical trials or "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=41857&idtype=1&closed=1" closed clinical trials using this agent. ("http://nciterms.nci.nih.gov:80/NCIBrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C473" NCI Thesaurus)

ID

http://purl.bioontology.org/ontology/PDQ/CDR0000041857

cui

C0014563

Date last modified

2007-01-15

definition

The synthetic form of the naturally occurring sympathomimetic amine with bronchodilating, intraocular pressure reducing, and vasoconstricting activity. By stimulating alpha adrenergic receptors, this agent causes vasoconstriction, thereby increasing vascular resistance and blood pressure. When administered in the conjunctiva, epinephrine binds to alpha-adrenergic receptors in the iris sphincter muscle, thereby causing vasoconstriction and a decrease in the production of aqueous humor. Through its beta1-receptor stimulating actions, this agent increases the force and rate of myocardial contraction and relaxes bronchial smooth muscle, thereby causing bronchodilatation. Check for "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=41857&idtype=1" active clinical trials or "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=41857&idtype=1&closed=1" closed clinical trials using this agent. ("http://nciterms.nci.nih.gov:80/NCIBrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C473" NCI Thesaurus)

Legacy PDQ ID

5069

NCI ID

C473

notation

CDR0000041857

ORIG STY

Drug/agent

prefLabel

therapeutic epinephrine

tui

T125

T109

T121

Delete Subject Author Type Created
No notes to display
Create New Mapping

Delete Mapping To Ontology Source
http://purl.bioontology.org/ontology/UATC/A01AD01 ATC CUI
http://purl.bioontology.org/ontology/SNOMEDCT/387362001 SNOMEDCT CUI
http://purl.bioontology.org/ontology/RCD/X80FK RCD CUI
http://purl.bioontology.org/ontology/UATC/B02BC09 ATC CUI
http://purl.bioontology.org/ontology/UATC/R01AA14 ATC CUI
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C473 NCIT LOOM
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C473 NCIT LOOM
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C473 NCIT LOOM
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C473 NCIT LOOM
http://purl.bioontology.org/ontology/UATC/R03AA01 ATC CUI
http://purl.bioontology.org/ontology/CSP/2268-5502 CRISP CUI
http://purl.bioontology.org/ontology/RXNORM/3992 RXNORM CUI
http://purl.bioontology.org/ontology/MESH/D004837 MESH CUI
http://purl.bioontology.org/ontology/NDFRT/N0000146377 NDFRT CUI
http://purl.bioontology.org/ontology/NDFRT/N0000006261 NDFRT CUI
http://purl.bioontology.org/ontology/SNOMEDCT/65502005 SNOMEDCT CUI
http://purl.bioontology.org/ontology/UATC/S01EA01 ATC CUI
http://purl.bioontology.org/ontology/NDDF/001774 NDDF CUI
http://purl.bioontology.org/ontology/SNMI/C-68060 SNMI CUI
http://purl.bioontology.org/ontology/SNMI/F-B2110 SNMI CUI
http://purl.bioontology.org/ontology/LNC/LP15027-3 LOINC CUI
http://purl.bioontology.org/ontology/RCD/x02LH RCD CUI
http://purl.bioontology.org/ontology/UATC/C01CA24 ATC CUI
http://purl.bioontology.org/ontology/LNC/MTHU002341 LOINC CUI
http://purl.bioontology.org/ontology/VANDF/4018034 VANDF CUI